Recently, green synthesis of silver nanoparticles has attracted much curiosity in the field of life science research. In the present study, we have reported a green method for synthesis of silver nanoparticles (AgNPs) using aqueous seed extract of Phoenix sylvestris L. The green synthesized nanoparticles were characterized by aids of dynamic light scattering, scanning electron microscopy, transmission electron microscopy, X-ray diffraction, and Fourier transform-infrared. Further, the study demonstrate the comparative phytochemical analysis as well as antioxidant and antibacterial activity of the extract and Phoenix sylvestris seed generated nanoparticles against acne-causing pathogens, that is, by using a DPPH-scavenging assay and broth microdilution method as well as Kirby–Bauer Disk diffusion method (recommended by CLSI), respectively. Moreover, a concentration-dependent time-kill kinetic studies were also carried out to determine their antimicrobial activity. The seed extract was found a better antioxidant and AgNPs exhibited highly biocidal agent against both the test pathogens, when compared to aqueous extracts. The results obtained indicate that seed extract of P. sylvestris is suitable for synthesizing stable silver nanoparticles, which act as excellent antimicrobial agents with promising treatments for cosmetics embarrassment. GRAPHICAL ABSTRACT

Skin disease associated with keratinized tissues in animal and human beings has been investigated. The essential oil of Eucalyptus pauciflora in vitro showed strong antifungal activity at 1.0 μl/ml against human pathogenic fungi, viz. Epidermophyton floccosum, Microsporum audouinii, M. canis, M. gypseum, M. nanum, Trichophyton mentagrophytes, T. rubrum, T. tonsurans and T. violaceum. The oil has heavy doses of inoculum potential at 1.0 μl/ml. Moreover, it did not exhibit any adverse effects on mammalian skin up to 5% concentrations. Further, we formulated the oil in the form of ointment ‘BSHT’ (broad spectrum herbal therapy) (1% v/v) and subjected it to topical testing on patients attending the outpatient department of M.L.N. Medical College, Allahabad. Fifty patients were selected on the basis of KOH-positive results and diagnosed as either tinea pedis, tinea corporis or tinea cruris. After the second week of treatment, all patients were KOH-negative. At the end of medication, 60% of patients recovered completely and 40% showed significant improvement from the disease. No KOH-negative cases of relapse were observed when patients were re-examined after 2 months following the end of treatment. Thus, the ointment can be exploited commercially after undergoing successful multicenter clinical trials, which are in progress.